Search

Displaying results 4251 - 4260 of 8517 in total
  1. Drug

    Brensocatib

    go.drugbank.com/drugs/DB15638
    Approved

    [A274348] Brensocatib was approved by the US FDA on August 12, 2025, for use in adults and pediatric patients with NCFB.[L53808,L53813]

  2. Drug

    Custirsen

    go.drugbank.com/drugs/DB05487
    Investigational

    Custirsen acts as a selective estrogen receptor modulator (SERM), inhibiting the proliferation of estrogen-sensitive breast cancer cells.

  3. Drug

    E-6201

    go.drugbank.com/drugs/DB11687
    Investigational

    E6201 has been investigated for the treatment of Chronic Plaque Psoriasis.

  4. Drug

    Acetyl hexapeptide-3

    go.drugbank.com/drugs/DB11709
    Investigational

    Argireline has been used in trials studying the treatment of wrinkles.

  5. Drug

    Tegobuvir

    go.drugbank.com/drugs/DB11852
    Investigational

    Tegobuvir has been investigated for the treatment of Hepatitis C, Chronic.

  6. Drug

    Pilsicainide

    go.drugbank.com/drugs/DB12712
    Investigational

    Pilsicainide has been investigated for the treatment of Paroxysmal Atrial Fibrillation.

  7. Drug

    Olitigaltin

    go.drugbank.com/drugs/DB12895
    Investigational

    Olitigaltin has been investigated for the treatment of Idiopathic Pulmonary Fibrosis.

    Synonyms: Bis-(3-deoxy-3-(4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl)-B-D-galactopyranosyl) sulfane
  8. Drug

    Gacyclidine

    go.drugbank.com/drugs/DB13096
    Investigational

    Gacyclidine has been used in trials studying the treatment of Tinnitus.

  9. Drug

    Tropatepine

    go.drugbank.com/drugs/DB13252
    Experimental

    Tropatepine has been used in France for its antiparkinsons activities [A175024].

  10. Drug

    Vedroprevir

    go.drugbank.com/drugs/DB12037
    Investigational

    Vedroprevir has been investigated for the treatment of Hepatitis C, Chronic.